Pko Investment Management Joint Stock CO Gilead Sciences, Inc. Transaction History
Pko Investment Management Joint Stock CO
- $882 Billion
- Q1 2025
A detailed history of Pko Investment Management Joint Stock CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 3,000 shares of GILD stock, worth $324,000. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,000
Previous 6,000
50.0%
Holding current value
$324,000
Previous $554 Million
39.35%
% of portfolio
0.04%
Previous 0.07%
Shares
25 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.43 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.9 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.78 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...